SCHEMBL4011994

SCHEMBL4011994

Nc1cccc(C#CCBr)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.44
CYP3A4 P08684 2/20 0.42
CASP1 P29466 1/20 0.42
RECQL P46063 1/20 0.42
DRD2 P14416 1/20 0.42
DRD3 P35462 1/20 0.42
PIK3CA P42336 1/20 0.41
MTOR P42345 1/20 0.41
PDK1 Q15118 1/20 0.41
ASIC3 Q9UHC3 2/20 0.40
ADRB2 P07550 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
THPO P40225 1/20 0.38
HCRTR1 O43613 1/20 0.37
BLM P54132 1/20 0.36
PMP22 Q01453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20919125 0.82 CYP3A4 (0.59) FFAR1CYP3A4CASP1RECQLDRD2
SCHEMBL4968126 0.80 CYP3A4 (0.58) FFAR1CYP3A4CASP1RECQLPIK3CA
SCHEMBL13529220 0.80 FFAR1 (0.47) FFAR1CYP3A4CASP1RECQLDRD2
SCHEMBL2810465 0.80 FFAR1 (0.44) FFAR1CYP3A4CASP1RECQLDRD2
SCHEMBL7402987 0.80 FFAR1 (0.44) FFAR1CYP3A4CASP1RECQLDRD2
Hydrochloric Acid SCHEMBL25281417 0.80 BLM (0.61) FFAR1CYP3A4CASP1RECQLDRD2
SCHEMBL23426194 0.77 CYP2D6 (0.47) FFAR1CYP3A4CASP1RECQLDRD2
SCHEMBL5425213 0.77 ASIC3 (0.62) FFAR1CYP3A4CASP1RECQLDRD2
SCHEMBL9611202 0.76 FFAR1 (0.59) FFAR1CYP3A4CASP1RECQLPIK3CA
SCHEMBL2266577 0.76 CYP3A4 (0.52) FFAR1CYP3A4CASP1RECQLDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080722-A2 CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER CRYSTAX PHARMACEUTICALS, S.L. (ES) 2009-07-02 WO disclosed